You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 10,100,130


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,100,130
Title:Dual specificity antibody fusions
Abstract: The present invention provides dual specificity antibody fusion proteins comprising an antibody Fab or Fab\' fragment with specificity for an antigen of interest, said fragment being fused to at least one single domain antibody which has specificity for a second antigen of interest.
Inventor(s): Humphreys; David Paul (Slough, GB), Dave; Emma (Slough, GB), Griffin; Laura (Slough, GB), Heywood; Sam Philip (Slough, GB)
Assignee: UCB BIOPHARMA SPRL (Brussels, BE)
Application Number:15/792,373
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of United States Patent 10,100,130: A Comprehensive Analysis

Introduction

When analyzing the scope and claims of a patent, such as United States Patent 10,100,130, it is crucial to delve into several key aspects, including the patent's claims structure, the legal framework governing patent eligibility, and strategic approaches to claim management. Here, we will provide a detailed analysis of these elements to help business professionals and patent practitioners navigate the complex landscape of patent law.

Patent Claims Structure

The structure of patent claims is fundamental in defining the scope of protection for an invention. A patent typically includes independent and dependent claims, each serving a distinct purpose.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are critical because they establish the broadest scope of protection for the invention. For example, in the context of AI-related inventions, the 2024 USPTO guidance update emphasizes the importance of integrating judicial exceptions into practical applications within these independent claims to ensure patent eligibility[1].

Dependent Claims

Dependent claims, on the other hand, refer back to and further limit an independent claim. They are used to narrow the scope of the invention and provide additional details that can help in defending the patent against potential challenges. Strategic management of dependent claims can maximize the patent’s breadth and flexibility without incurring additional costs[2].

Legal Framework for Patent Eligibility

The eligibility of a patent is governed by Section 101 of the U.S. Patent Act, which has been subject to various interpretations and updates.

Judicial Exceptions and Practical Applications

The 2024 USPTO guidance update clarifies that claims must integrate judicial exceptions (such as abstract ideas, natural phenomena, and laws of nature) into practical applications to be considered patent-eligible. This involves assessing whether additional elements in the claim impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

AI-Assisted Inventions

The update also addresses AI-assisted inventions, stating that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI’s role as a tool does not exclude inventions from eligibility, provided there is significant human contribution[1].

Strategic Claim Management

Effective claim management is vital for maximizing the value and protective scope of a patent.

Claim Composition and Management

It is a common misconception that the quantity of claims directly correlates with a patent's strength or value. However, the strategic composition and management of these claims can significantly enhance a patent’s effectiveness. For instance, consolidating multiple dependent claims into fewer, broader independent claims can facilitate application approval and ensure comprehensive protection of the invention[2].

Utilizing Full Quota of Claims

Practitioners should ensure that the final patent utilizes the full quota of claims entitled by the filing fee. This involves adding a new dependent claim for every claim that is canceled, thereby maximizing the patent’s breadth and flexibility without additional costs[2].

Measuring Patent Scope

Patent scope is a critical aspect of patent quality and can be measured using various metrics.

Independent Claim Length and Count

Research suggests that independent claim length and count can serve as simple yet effective metrics for measuring patent scope. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Real-World Applications and Practical Utility

Demonstrating the real-world applications and practical utility of the claimed method or system is essential for bolstering the argument for patent eligibility.

Example from 2024 USPTO Guidance

For instance, Claim 2 in the 2024 USPTO guidance update specifies the use of separated audio components in a real-time speech recognition system to enhance the accuracy of voice commands in hands-free environments. This practical application transforms the abstract idea into a specific, practical application that provides clear benefits, such as improved accuracy in speech recognition systems[1].

Claim Construction and Infringement

Claim construction is a critical step in determining the scope of a patent and whether infringement has occurred.

Legal Principles of Claim Construction

The court construes patent claims without the aid of a jury, giving the words of a claim their ordinary and customary meaning. This process involves determining the meaning and scope of the relevant claims and comparing them to the accused device[5].

Case Law and Prosecution Histories

Understanding case law and the prosecution histories of similar patents can provide valuable insights.

Example from Samsung Case

In the case involving Samsung, the court considered the prosecution histories of the asserted patents and the applicable law to render its order on claims construction. This highlights the importance of thorough documentation and legal analysis in patent litigation[5].

Key Takeaways

  • Integrate Judicial Exceptions: Ensure that claims integrate judicial exceptions into practical applications to meet patent eligibility criteria.
  • Strategic Claim Management: Utilize the full quota of claims and strategically manage dependent claims to maximize patent breadth and flexibility.
  • Real-World Applications: Highlight the real-world applications and practical utility of the claimed method or system to bolster patent eligibility.
  • Claim Construction: Understand the legal principles of claim construction and the importance of clear claim language.
  • Patent Scope Metrics: Use metrics such as independent claim length and count to measure and optimize patent scope.

FAQs

Q: How does the 2024 USPTO guidance update impact AI-related patent applications? A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on the claimed invention itself rather than the method of invention development. It also provides examples to help practitioners draft claims that integrate judicial exceptions into practical applications[1].

Q: What is the importance of independent claims in a patent application? A: Independent claims define the invention broadly and establish the scope of protection. They are crucial for ensuring that the patent covers the core aspects of the invention[2].

Q: How can practitioners maximize the value of their patent through claim management? A: Practitioners can maximize the value by ensuring the patent utilizes its full quota of claims, consolidating multiple dependent claims into broader independent claims, and adding new dependent claims for every canceled claim[2].

Q: What metrics can be used to measure patent scope? A: Metrics such as independent claim length and count can be used to measure patent scope. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments and forward citations[3].

Q: Why is claim construction important in patent litigation? A: Claim construction is essential because it determines the meaning and scope of the relevant claims, which is then compared to the accused device to determine infringement. Clear claim language and proper construction are critical for successful patent litigation[5].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. Maximizing Patent Value: A Strategic Approach to Claim Management - Harrity LLP.
  3. Patent Claims and Patent Scope - SSRN.
  4. What Is the Probability of Receiving a US Patent? - YJOLT.
  5. Case 1:17-cv-00030-LY Document 72 Filed 06/08/18 - GovInfo.

More… ↓

⤷  Subscribe

Details for Patent 10,100,130

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 October 21, 1942 10,100,130 2027-09-26
Takeda Pharmaceuticals U.s.a., Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 March 03, 1954 10,100,130 2027-09-26
Csl Behring Ag ALBURX albumin (human) Injection 102366 July 23, 1976 10,100,130 2027-09-26
Grifols Biologicals Llc ALBUTEIN albumin (human) Injection 102478 August 15, 1978 10,100,130 2027-09-26
Grifols Biologicals Llc ALBUTEIN albumin (human) Injection 102478 November 29, 2022 10,100,130 2027-09-26
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 February 17, 1995 10,100,130 2027-09-26
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 June 11, 2003 10,100,130 2027-09-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.